Global Oligonucleotides Market Size, Status and Forecast 2021-2027

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide is widely used in Research, Pharmaceutical and Diagnostic. The most proportion of Oligonucleotide used in Research, and the revenue in 2018 is 409.97 M USD. Moreover, increase in focus on targeted gene therapies has revolutionized treatment of incurable conditions caused by genetic mutations. Increase in demand for sequencing applications by clinical, diagnostic, academic, and drug development is witnessed by manufactures.

Market Analysis and Insights: Global Oligonucleotides Market
The global Oligonucleotides market size is projected to reach US$ 2102.4 million by 2027, from US$ 1072 million in 2020, at a CAGR of 10.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oligonucleotides market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oligonucleotides market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oligonucleotides market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oligonucleotides market.

Global Oligonucleotides Scope and Market Size
Oligonucleotides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DNA Oligos
RNA Oligos

Segment by Application
Pharmaceutical
Research
Diagnostic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems